Neutral endopeptidase up-regulation in isolated human umbilical artery: Involvement in desensitization of bradykinin-induced vasoconstrictor effects

Journal of Pharmacology and Experimental Therapeutics

Volumn 320, Issue 2, 2007, Pages 713-720

  Pelorosso, Facundo Germán ^a   Halperin, Ana Verónica ^a   Palma, Alejandro Martín ^a   Nowak, Wanda ^a   Errasti, Andrea Emilse ^a   Rothlin, Rodolfo Pedro ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b NONE   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ANILIDE; BRADYKININ; CAPTOPRIL; CELL EXTRACT; CYCLOHEXIMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LEUCINE; MEMBRANE METALLOENDOPEPTIDASE; PHOSPHORAMIDON; VASOCONSTRICTOR AGENT;

ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DRUG EFFECT; DRUG HYDROLYSIS; DRUG INHIBITION; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; IN VITRO STUDY; INCUBATION TIME; ISOLATION PROCEDURE; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; UMBILICAL ARTERY; VASOCONSTRICTION; WESTERN BLOTTING;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BRADYKININ; GLYCOPEPTIDES; HUMANS; NEPRILYSIN; PROTEIN BIOSYNTHESIS; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; TIME FACTORS; UMBILICAL ARTERIES; UP-REGULATION; VASOCONSTRICTION;

EID: 33846450655     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.113381     Document Type: Article

References (46)

1. Abbas F, Clayton JK, Marshall KM, and Senior J (1998) Characterisation of kinin receptors on the human isolated umbilical artery. J Endocrinol 156:389-394.
2. Altura BM, Malaviya D, Reich CF, and Orkin LR (1972) Effects of vasoactive agents on isolated human umbilical arteries and veins. Am J Physiol 222:345-355.
3. Angers M, Drouin R, Bachvarova M, Paradis I, Marceau F, and Bachvarov DR (2000) In vivo protein-DNA interactions at the kinin B1 receptor gene promoter: no modification on interleukin-1β or lipopolysaccharide induction. J Cell Biochem 78:278-296.
4. Audet R, Petitclerc E, Drapeau G, Rioux F, and Marceau F (1994) Further analysis of the upregulation of bradykinin B1 receptors in isolated rabbit aorta by using metabolic inhibitors. Eur J Pharmacol 271:551-555.
5. 2 receptor endocytosis, recycling, and down-regulation assessed using green fluorescent protein conjugates. J Pharmacol Exp Ther 297:19-26.
6. Bathon JM and Proud D (1991) Bradykinin antagonists. Annu Rev Pharmacol Toxicol 31:129-162.
7. Campos MM, Souza GE, and Calixto JB (1996) Upregulation of B1 receptor mediating des-Arg9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin. Br J Pharmacol 117:793-798.
8. Christiansen SC, Eddleston J, Woessner KM, Chambers SS, Ye R, Pan ZK, and Zuraw BL (2002) Up-regulation of functional kinin B1 receptors in allergic airway inflammation. J Immunol 169:2054-2060.
9. Cruwys SC, Garrett NE, Perkins MN, Blake DR, and Kidd BL (1994) The role of bradykinin B1 receptors in the maintenance of intra-articular plasma extravasation in chronic antigen-induced arthritis. Br J Pharmacol 113:940-944.
10. Deblois D and Marceau F (1987) The ability of des-Arg9-bradykinin to relax rabbit isolated mesenteric arteries is acquired during in vitro incubation. Eur J Pharmacol 142:141-144.
11. 2 receptor. Hypertension 39:619-623.
12. DeLean A, Munson PJ, and Rodbard D (1978) Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235:97-102.
13. Dendorfer A, Reibetamann S, Wolfrum S, Raasch W, and Dominiak P (2001) Potentiation of kinin analogues by ramiprilat is exclusively related to their degradation. Hypertension 38:142-146.
14. Dendorfer A, Wagemann M, Reissmann S, and Dominiak P (1999) Structural requirements for B2-agonists with improved degradation stability. Immunopharmacology 45:199-205.
15. Dray A and Perkins M (1993) Bradykinin and inflammatory pain. Trends Neurosci 16:99-104.
16. El Sayah M, Medeiros R, Fernandes ES, Campos MM, and Calixto JB (2006) Mechanisms underlying lipopolysaccharide-induced kinin B1 receptor upregulation in the pig iris sphincter in vitro. Mol Pharmacol 69:1701-1708.
17. Erdos EG (1990) Some old and some new ideas on kinin metabolism. J Cardiovasc Pharmacol 15:S20-24.
18. Feletou M, Martin CA, Molimard M, Naline E, Germain M, Thurieau C, Fauchere JL, Canet E, and Advenier C (1995) In vitro effects of HOE 140 in human bronchial and vascular tissue. Eur J Pharmacol 274:57-64.
19. Fortin JP, Gera L, Bouthillier J, Stewart JM, Adam A, and Marceau F (2005) Endogenous aminopeptidase N decreases the potency of peptide agonists and antagonists of the kinin B1 receptors in the rabbit aorta. J Pharmacol Exp Ther 314:1169-1176.
20. Gafford JT, Skidgel RA, Erdos EG, and Hersh LB (1983) Human kidney "enkephalinase," a neutral metalloendopeptidase that cleaves active peptides. Biochemistry 22:3265-3271.
21. Hoang MV and Turner AJ (1997) Novel activity of endothelin-converting enzyme: hydrolysis of bradykinin. Biochem J 327:23-26.
22. Kukkola PJ, Savage P, Sakane Y, Berry JC, Bilci NA, Ghai RD, and Jeng AY (1995) Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: endothelin-converting enzyme, neutral endopeptidase, and angiotensin-converting enzyme. J Cardiovasc Pharmacol 26:S65-S68.
23. Leeb-Lundberg LM, Marceau F, Muller-Esterl W, Pettibone DJ, and Zuraw BL (2005) International Union of Pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 57:27-77.
24. Loffler BM (2000) Endothelin-converting enzyme inhibitors: current status and perspectives. J Cardiovasc Pharmacol 35:S79-S82.
25. Marceau F (1995) Kinin B1 receptors: a review. Immunopharmacology 30:1-26.
26. Marceau F, Hess JF, and Bachvarov DR (1998) The B1 receptors for kinins. Pharmacol Rev 50:357-386.
27. McEachern AE, Shelton ER, Bhakta S, Obernolte R, Bach C, Zuppan P, Fujisaki J, Aldrich RW, and Jarnagin K (1991) Expression cloning of a rat B2 bradykinin receptor. Proc Natl Acad Sci USA 88:7724-7728.
28. Medeiros R, Cabrini DA, Ferreira J, Fernandes ES, Mori MA, Pesquero JB, Bader M, Avellar MC, Campos MM, and Calixto JB (2004) Bradykinin B1 receptor expression induced by tissue damage in the rat portal vein: a critical role for mitogen-activated protein kinase and nuclear factor-κB signaling pathways. Circ Res 94:1375-1382.
29. Menke JG, Borkowski JA, Bierilo KK, MacNeil T, Derrick AW, Schneck KA, Ransom RW, Strader CD, Linemeyer DL, and Hess JF (1994) Expression cloning of a human B1 bradykinin receptor. J Biol Chem 269:21583-21586.
30. Miyamoto A, Murata S, and Nishio A (2002) Role of ACE and NEP in bradykinin-induced relaxation and contraction response of isolated porcine basilar artery. Naunyn-Schmiedeberg's Arch Pharmacol 365:365-370.
31. 2 receptors in acute renal transplant rejection. Immunopharmacology 33:157-160.
32. Olerud JE, Usui ML, Seckin D, Chiu DS, Haycox CL, Song IS, Ansel JC, and Bunnett NW (1999) Neutral endopeptidase expression and distribution in human skin and wounds. J Investig Dermatol 112:873-881.
33. 9-kallidin-induced vasoconstrictor responses by metallopeptidase inhibition in isolated human umbilical artery. J Pharmacol Exp Ther 313:1355-1360.
34. Proud D, Baumgarten CR, Naclerio RM, and Ward PE (1987) Kinin metabolism in human nasal secretions during experimentally induced allergic rhinitis. J Immunol 138:428-434.
35. Regoli D, Barabe J, and Park WK (1977) Receptors for bradykinin in rabbit aortae. Can J Physiol Pharmacol 55:855-867.
36. Reissmann S, Schwuchow C, Seyfarth L, Pineda De Castro LF, Liebmann C, Paegelow I, Werner H, and Stewart JM (1996) Highly selective bradykinin agonists and antagonists with replacement of proline residues by N-methyl-D- and L-phenylalanine. J Med Chem 39:929-936.
37. Roques BP, Noble F, Crine P, and Fournie-Zaluski MC (1995) Inhibitors of neprilysin: design, pharmacological and clinical applications. Methods Enzymol 248:263-283.
38. 1 receptor up-regulation in human umbilical vein. J Pharmacol Exp Ther 290:1019-1025.
39. 1 receptors in human umbilical vein. Eur J Pharmacol 321:33-38.
40. 1 receptor-sensitized responses in human umbilical vein. J Pharmacol Exp Ther 301:975-980.
41. Schremmer-Danninger E, Hermann A, Fink E, Fritz H, and Roscher AA (1999) Identification and occurrence of mRNAs for components of the kallikrein-kinin system in human skin and in skin diseases. Immunopharmacology 43:287-291.
42. 1 bradykinin receptors and carboxypeptidase M are both upregulated in the aorta of pigs after LPS infusion. Biochem Biophys Res Commun 243:246-252.
43. Tom B, Dendorfer A, and Danser AH (2003) Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact? Int J Biochem Cell Biol 35:792-801.
44. Tom B, Dendorfer A, de Vries R, Saxena PR, and Jan Danser AH (2002) Bradykinin potentiation by ACE inhibitors: a matter of metabolism. Br J Pharmacol 137:276-284.
45. Tufan H, Ayan-Polat B, Tecder-Unal M, Polat G, Kayhan Z, and Ogus E (2003) Contractile responses of the human umbilical artery to KCl and serotonin in Ca-free medium and the effects of levcromakalim. Life Sci 72:1321-1329.
46. Walther T, Siems WE, Hauke D, Spillmann F, Dendorfer A, Krause W, Schultheiss HP, and Tschope C (2002) AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats. FASEB J 16:1237-1241.